MENU
+Compare
TELA
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$0.99
Change
+$0.04 (+4.21%)
Capitalization
139.76M

TELA TELA Bio Forecast, Technical & Fundamental Analysis

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy... Show more

TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TELA with price predictions
May 08, 2025

TELA sees its Stochastic Oscillator ascends from oversold territory

On April 24, 2025, the Stochastic Oscillator for TELA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 63 instances where the indicator left the oversold zone. In of the 63 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TELA's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 01, 2025. You may want to consider a long position or call options on TELA as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TELA just turned positive on April 14, 2025. Looking at past instances where TELA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TELA advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TELA entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.983) is normal, around the industry mean (24.089). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.093) is also within normal values, averaging (42.249).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TELA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TELA is expected to report earnings to fall 14.13% to -19 cents per share on May 08

TELA Bio TELA Stock Earnings Reports
Q1'25
Est.
$-0.20
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.26
The last earnings report on March 20 showed earnings per share of -23 cents, missing the estimate of -21 cents. With 114.51K shares outstanding, the current market capitalization sits at 139.76M.
A.I. Advisor
published General Information

General Information

a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1 Great Valley Parkway
Phone
+1 484 320-2930
Employees
227
Web
https://www.telabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IIIIX12.62N/A
N/A
Voya International Index Port I
TBGVX28.15N/A
N/A
Tweedy, Browne International Value Fund
RYREX39.16N/A
N/A
Rydex Real Estate A
MDSPX25.28N/A
N/A
BlackRock Advantage SMID Cap Inv A
JSMVX16.95N/A
N/A
Jackson Square SMID-Cap Growth Inv

TELA and Stocks

Correlation & Price change

A.I.dvisor tells us that TELA and HBIO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and HBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELA
1D Price
Change %
TELA100%
+4.26%
HBIO - TELA
29%
Poorly correlated
+1.53%
ATR - TELA
28%
Poorly correlated
+1.30%
MTD - TELA
27%
Poorly correlated
+1.58%
TFX - TELA
27%
Poorly correlated
+3.36%
KRMD - TELA
26%
Poorly correlated
+20.96%
More